Here's why these 3 stocks are soaring higher today

Sirtex Medical Limited (ASX:SRX) and Ansell Limited (ASX:ANN) are flying the flag for healthcare stocks.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On a day that looks like seeing the S&P / ASX 200 (Index: ^AXJO) (ASX: XJO) snap its record-breaking winning streak there are several healthcare and engineering businesses breaking the mould to fly higher. Let's take a look at them and consider what could be behind the moves.

Ansell Limited (ASX: ANN) is a condom and protective glove maker that posted better-than-expected half-year results today. The company posted a net profit of US$87.7 million on revenues of US$847.3 million and said it had seen strong sales, acquisition outperformance and improved margins.

The stock has lifted 4.9% in response and given Ansell's global exposure and opportunity to move into emerging markets it remains a solid future bet. Ansell also has distribution agreements with Starpharma Holdings Limited (ASX: SPL), which has gained 4 cents or 8% today.

MMA Offshore Ltd (ASX: MRM) the company formerly known as Mermaid Marine Australia has soared 7.26% to 97.5 cents, but remains down around 66% over the past year. The falls are related to the company's exposure to servicing the oil and gas sector. Any sign of a decisive rebound in oil prices will likely prove a turning point for Mermaid Marine, this is because it is partly reliant for future work on new investment in the energy sector.

Today has likely seen some bargain hunting from investors who believe the company's outlook is not as gloomy as beaten-down prices suggest.

Sirtex Medical Limited (ASX: SRX) is an innovative cancer treatment business with an evangelical-like following among some retail and institutional investors. The stock has rocketed more than 5% today to a record high of $31.21, as a consistently positive news flow keeps investor sentiment bullish on the company's outlook.

The business currently has several clinical trials in progress including SIRFLOX, FOXFIRE and FOXFIRE Global, all of which are aimed at proving the effectiveness of its radiation therapy product in treating cancer. If it is able to translate clinical trial success into fast-growing sales the stock could keep climbing. However, given its valuation investors should probably put this one on the watchlist and wait for the company's half-year report to be delivered on February 18.

Motley Fool contributor Tom Richardson owns shares in Sirtex Medical. You can find him on Twitter @tommyr345

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »